As per reports, St. Louis-based mesothelioma law firm of Maune Raichle Hartley French & Mudd representing Donna and Robert Olson on their claim of lifetime exposure to asbestos causing terminal mesothelioma due to the usage of Johnson’s Baby Powder and Shower won a $325 million award in New York last week. The Olson’s who live in Delaware got $25 million in compensatory damages & $300 million in punitive damages.
Johnson & Johnson informed “This trial suffered significant legal and evidentiary errors which Johnson & Johnson believes will warrant a reversal on appeal. Decades of tests by independent experts and academic institutions repeatedly confirm that Johnson’s Baby Powder does not contain asbestos or cause cancer. Of all the verdicts against Johnson & Johnson that have been through the appellate process, everyone has been overturned. Further, there have been several trials where juries have concluded that Johnson & Johnson’s product was not responsible for the plaintiffs’ cancer, and in other instances, judges have dismissed cases outright, based on their own review of the facts.” in an email to Business Journal.
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive!